Related references
Note: Only part of the references are listed.Magnetic resonance evaluation of hepatic and myocardial iron deposition in transfusion-independent thalassemia intermedia compared to regularly transfused thalassemia major patients
Ali T. Taher et al.
AMERICAN JOURNAL OF HEMATOLOGY (2010)
Absence of cardiac siderosis despite hepatic iron overload in Italian patients with thalassemia intermedia: an MRI T2*study
Alberto Roghi et al.
ANNALS OF HEMATOLOGY (2010)
Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study
Ali T. Taher et al.
BLOOD (2010)
Treatment with deferasirox (Exjade (R)) effectively decreases iron burden in patients with thalassaemia intermedia: results of a pilot study
Ersi Voskaridou et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Effect of combination therapy of hydroxyurea with l-carnitine and magnesium chloride on hematologic parameters and cardiac function of patients with beta-thalassemia intermedia
Mehran Karimi et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Paraspinal extramedullary hematopoiesis in patients with thalassemia intermedia
Rachid Haidar et al.
EUROPEAN SPINE JOURNAL (2010)
A genome-wide association identified the common genetic variants influence disease severity in β0-thalassemia/hemoglobin E
Manit Nuinoon et al.
HUMAN GENETICS (2010)
International Reproducibility of Single Breathhold T2*MR for Cardiac and Liver Iron Assessment Among Five Thalassemia Centers
Paul Kirk et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2010)
Asymptomatic brain magnetic resonance imaging abnormalities in splenectomized adults with thalassemia intermedia
A. T. Taher et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Splenectomy and thrombosis: the case of thalassemia intermedia
A. T. Taher et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Amelioration of Sardinian β0 thalassemia by genetic modifiers
Renzo Galanello et al.
BLOOD (2009)
The HBS1L-MYB intergenic interval associated with elevated HbF levels shows characteristics of a distal regulatory region in erythroid cells
Karin Wahlberg et al.
BLOOD (2009)
Iron overload in thalassaemia intermedia: reassessment of iron chelation strategies
Ali Taher et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Levels of non-transferrin-bound iron as an index of iron overload in patients with thalassaemia intermedia
Ali Taher et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association
Vallerie V. McLaughlin et al.
CIRCULATION (2009)
The Hypercoagulable State in Thalassemia Intermedia
Ali T. Taher et al.
HEMOGLOBIN (2009)
Iron Overload: Consequences, Assessment, and Monitoring
Ali T. Taher et al.
HEMOGLOBIN (2009)
Developmental and species-divergent globin switching are driven by BCL11A
Vijay G. Sankaran et al.
NATURE (2009)
Continuous increase in erythropoietic activity despite the improvement in bone mineral density by zoledronic acid in patients with thalassemia intermedia-induced osteoporosis
Ersi Voskaridou et al.
ACTA HAEMATOLOGICA (2008)
Vitamin E Supplementation Reduces Oxidative Stress in Beta Thalassaemia Intermedia
W. P. Pfeifer et al.
ACTA HAEMATOLOGICA (2008)
Complications of splenectomy
Ali Cadili et al.
AMERICAN JOURNAL OF MEDICINE (2008)
Thalidomide therapy in a patient with thalassemia major
Lilia Beatriz Aguilar-Lopez et al.
BLOOD CELLS MOLECULES AND DISEASES (2008)
Studies in haemoglobin E beta-thalassaemia
Nancy F. Olivieri et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Correlation of liver iron concentration determined by R2 magnetic resonance imaging with serum ferritin in patients with thalassemia intermedia
Ali Taher et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2008)
Continuous improvement of bone mineral density two years post zoledronic acid discontinuation in patients with thalassemia-induced osteoporosis: long-term follow-up of a randomized, placebo-controlled trial
Ersi Voskaridou et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2008)
Pregnancy outcome in patients with beta-thalassemia intermedia at two tertiary care centers, in Beirut and Milan
Anwar H. Nassar et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2008)
Pomalidomide and lenalidomide regulate erythropoiesis and fetal hemoglobin production in human CD34(+) cells
Laure A. Moutouh-de Parseval et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and Amelioration of the phenotype of β-thalassemia
Manuela Uda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A
Vijay G. Sankaran et al.
SCIENCE (2008)
A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15
Stephan Menzel et al.
NATURE GENETICS (2007)
β-thalassaemia and sickle cell anaemia as paradigms of hypercoagulability
Kenneth I. Ataga et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Modern treatment of thalassaemia intermedia
Caterina Borgna-Pignatti
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Age-related changes in adaptation to severe anemia in childhood in developing countries
Angela O'Donnell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Thalassemia intermedia today: should patients regularly receive transfusions?
Athanassios Aessopos et al.
TRANSFUSION (2007)
A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease
Elliott Vichinsky et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Chronic pulmonary thromboembolism revealing beta-thalassemia intermedia after splenectomy
B. Pierre et al.
REVUE DE MEDECINE INTERNE (2006)
Cytoprotective effects of the antioxidant phytochemical indicaxanthin in β-thalassemia red blood cells
L. Tesoriere et al.
FREE RADICAL RESEARCH (2006)
Thalassemia intermedia: Revisited
Ali Taher et al.
BLOOD CELLS MOLECULES AND DISEASES (2006)
Low serum levels of 25-hydroxy vitamin D in adults affected by thalassemia major or intermedia
N. Napoli et al.
BONE (2006)
A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with β-thalassemia
MD Cappellini et al.
BLOOD (2006)
Treatment with hydroxycarbamide for intermedia thalassaemia: decrease of efficacy in some patients during long-term follow up
A Mancuso et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
beta-Thalassemia intermedia and pregnancy: should we anticoagulate?
A. H. Nassar et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Fetal haemoglobin augmentation in E/β0 thalassaemia:: clinical and haematological outcome
ST Singer et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
A novel molecular basis for β thalassemia intermedia poses new questions about its pathophysiology
A Premawardhena et al.
BLOOD (2005)
MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients
JC Wood et al.
BLOOD (2005)
Hematologic and clinical responses of thalassemia intermedia patients to hydroxyurea during 6 years of therapy in Iran
M Karimi et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2005)
Hydroxyurea in thalassemia intermedia - a promising therapy
A Dixit et al.
ANNALS OF HEMATOLOGY (2005)
Overcoming the challenge of patient compliance with iron chelation therapy
MD Cappellini
SEMINARS IN HEMATOLOGY (2005)
Butyrate increases the efficiency of translation of γ-globin mRNA
RS Weinberg et al.
BLOOD (2005)
Do alpha deletions influence hydroxyurea response in thalassemia intermedia?
I Panigrahi et al.
HEMATOLOGY (2005)
Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance
TG St Pierre et al.
BLOOD (2005)
Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease
E Voskaridou et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Pulmonary arterial hypertension in previously splenectomized patients with β-thalassemic disorders
V Atichartakarn et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2003)
Clinical trial of deferiprone iron chelation therapy in β-thalassaemia/haemoglobin E patients in Thailand
P Pootrakul et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Effects of N-acetylcysteine on dense cell formation in sickle cell disease
BS Pace et al.
AMERICAN JOURNAL OF HEMATOLOGY (2003)
In vivo platelet activation and hyperaggregation in hemoglobin E/β-thalassemia:: A consequence of splenectomy
V Atichartakarn et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2003)
Biophysical characterization of the α-globin binding protein α-hemoglobin stabilizing protein
D Gell et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Relationship between hypercoagulable state and erythrocyte phosphatidylserine exposure in splenectomized haemoglobin E/β-thalassaemic patients
V Atichartakarn et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Long-term treatment with oral sildenafil in a thalassemic patient with pulmonary hypertension
R Littera et al.
BLOOD (2002)
Treatment with hydroxyurea in thalassemia intermedia with paravertebral pseudotumors of extramedullary hematopoiesis
H Cario et al.
ANNALS OF HEMATOLOGY (2002)
An abundant erythroid protein that stabilizes free α-haemoglobin
AJ Kihm et al.
NATURE (2002)
Pulmonary thromboembolism in beta-thalassemia intermedia: Are we aware of this complication?
A Taher et al.
HEMOGLOBIN (2002)
Risk of infection and death among post-splenectomy patients
N Bisharat et al.
JOURNAL OF INFECTION (2001)
Cardiac involvement in thalassemia intermedia: a multicenter study
A Aessopos et al.
BLOOD (2001)
Phenotype-genotype relationships in monogenic disease: Lessons from the thalassaemias
DJ Weatherall
NATURE REVIEWS GENETICS (2001)
Oral supplements of vitamin E improve measures of oxidative stress in plasma and reduce oxidative damage to LDL and erythrocytes in beta-thalassemia intermedia patients
L Tesoriere et al.
FREE RADICAL RESEARCH (2001)
Membrane-bound iron contributes to oxidative damage of beta-thalassaemia intermedia erythrocytes
D Tavazzi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia
MD Cappellini et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
Oral isobutyramide therapy in patients with thalassemia intermedia: Results of a phase II open study
MD Cappellini et al.
BLOOD CELLS MOLECULES AND DISEASES (2000)
Share Paper
